http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1697814-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_592638d9e8f3946ee52e303f6335f38a |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 |
| filingDate | 1981-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1991-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f8592d5d2713670d63c69e333ededa0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92d24f8d54452b1c78482d385c9937ec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81517a684673445d16caaf36dd1c5f0d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d12607dfef39854a28bc01a77873420 |
| publicationDate | 1991-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | SU-1697814-A1 |
| titleOfInvention | Agent for basaliom treatment |
| abstract | The invention relates to pharmaceutical compositions for the treatment of dermatoses associated with impaired keratonization and epidermosis, and relates to preparations for the treatment of basalitis, developing from a fine spot, nodule or limited hyperkeratosis. The aim of the invention is to increase specific activity and reduce toxicity. The tool is obtained as follows. 1.2 g of sodium hydroxide, 1.25 g of sodium carbonate, and 7.5 g of fluoro-fura are dissolved in 57.25 g of water. The resulting solution is heated to 80-85 ° C and a thin stream is poured with vigorous stirring into an alloy of fatty components consisting of 14.0 g of diethylene glycol stearate, 1.5 g of triethanolamine stearate, 5.0 g of stearin, 8.0 g olive oil, 0.1 g nipagina and 0.2 g nipazol. The emulsification is carried out at 70-75 ° C for 20 minutes, then continued at a gradually decreasing temperature, which after 35-40 minutes should be 18-20 ° C. Prepared ointment packaged in tubes. The use of the proposed remedy makes it possible to shorten the treatment time, ensures the absence of a general toxic effect, the normalization of the clinical and histological picture of hyperkeratosis, and the absence of relapses. fe |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-4323615-A1 |
| priorityDate | 1981-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 51.